New approaches to the prevention of organ allograft rejection and tolerance induction.
The therapeutic use of organ allograft transplantation is dependent on the discovery and clinical application of immunologic strategies to blunt the immune response and prevent graft rejection. It was the discovery of powerful immunotherapeutics such as cyclosporine A and rapamycin that has allowed for the widespread use of organ transplantation to treat organ failure. However, despite the attainment of impressive survival rates 1 year after organ transplantation, a significant number of organ allografts are lost to immune-mediated chronic rejection. Furthermore, significant morbidity and mortality can be associated with the use of currently available immunosuppressive regimens. Thus, the development of novel approaches to prevent of organ allograft rejection remains extremely important. Here we discuss two promising and novel avenues of research. First, the discovery and characterization of naturally occurring immune inhibitory signals have led to recent research aimed at exploiting these pathways to induce peripheral tolerance to alloantigen. Furthermore, we discuss new approaches to the induction of donor-specific tolerance by induction of molecular chimerism and the transfer of alloantigen-expressing mature T cells.
Bagley
Jessamyn
J
Transplantation Research Center, Brigham and Women's Hospital and Children's Hospital Boston, Harvard Medical School, 221 Longwood Avenue, Boston, MA 02115, USA.
Tian
Chaorui
C
Iacomini
John
J
D000818:Animals; D018797:Cell Cycle Proteins / Q000145:classification / Q000276:immunology; D046528:Chimerism; D006084:Graft Rejection / Q000235:genetics / Q000276:immunology* / Q000517:prevention & control*; D006801:Humans; D007108:Immune Tolerance / Q000235:genetics / Q000276:immunology*; D047908:Intracellular Signaling Peptides and Proteins / Q000145:classification / Q000276:immunology; D015398:Signal Transduction / Q000276:immunology; D014184:Transplantation, Homologous / Q000276:immunology
D018797:Cell Cycle Proteins; D047908:Intracellular Signaling Peptides and Proteins